Skip to main content
Avidity Biosciences, Inc. (RNAM)
NASDAQ: RNAM · Real-Time Price · USD
72.86
+0.04 (0.05%)
Feb 27, 2026, 4:00 PM EST - Market closed

Avidity Biosciences Revenue

In the year 2025, Avidity Biosciences had annual revenue of $18.76M with 72.11% growth. Avidity Biosciences had revenue of $860.00K in the quarter ending December 31, 2025, a decrease of -71.07%.

Revenue (ttm)
$18.76M
Revenue Growth
+72.11%
P/S Ratio
602.73
Revenue / Employee
$36,703
Employees
511
Market Cap
11.30B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202518.76M7.86M72.11%
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 944.00M
BridgeBio Pharma 502.08M
ImmunityBio 113.29M
Avidity Biosciences 18.76M
Revenue Rankings

RNAM News

More News